MedDataX Logo

VEGF as a Prognostic Factor for White Matter Damage in Preterm Infants

NCT ID: NCT00564161

Last Updated: 2016-09-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2008-01-31

Study Completion Date

2009-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We hypothesize that misexpression of vascular endothelial growth factor (VEGF) in the Cerebrospinal fluid of preterm infants can be used as a biomarker to predict the risk for developing white matter damage.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Added Value of Supersonic Shear Imaging in the Diagnosis of White Matter Damage in Preterm Infants

NCT02042716

Preterm
COMPLETED NA

Optimizing Treatment of Post-hemorrhagic Ventricular Dilation in Preterm Infants

NCT00875758

Intraventricular Hemorrhage Hydrocephalus
COMPLETED NA

Maternal and Neonatal Risk Factors of HIE

NCT05749458

Hypoxic Ischemic Encephalopathy of Newborn
UNKNOWN

Sonographic QUantification of Venous Circulation In the Preterm Brain

NCT04535375

Prematurity; Extreme Cerebral Circulatory Failure Intraventricular Hemorrhage +1 more
COMPLETED NA

Transitional Cerebrovascular Reactivity in Very Preterm Infants

NCT04423016

Cerebral Autoregulation Preterm Birth Premature Infant Disease
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preterm Infants With White Matter Damage Preterm Infants Developing Normally

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

No interventions assigned to this group

2

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Preterm infants undergoing lumbar puncture.

Exclusion Criteria

* Preterm with IVH or known infection or meningitis.
Minimum Eligible Age

25 Weeks

Maximum Eligible Age

40 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hadassah Medical Organization

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Talya Dor, MD

Role: PRINCIPAL_INVESTIGATOR

Hadassah Medical Organization

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

606060-HMO-CTIL

Identifier Type: -

Identifier Source: secondary_id

606060-HMO-CTIL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prediction of Brain Injury in Premature Infants
NCT02814383 COMPLETED
Cerebral Oxygenation and Autoregulation in Preterm Infants
NCT02147769 COMPLETED
Improving Brain Development in Medically Healthy Premature Infants
NCT00065364 COMPLETED NA
Outcome of Intraventricular Hemorrhage in Preterm Infants
NCT07198360 NOT_YET_RECRUITING
The Relationship Between Superior Vena Cava Flow and Intraventricular Hemorrhage in Preterm Infants
NCT05050032 COMPLETED
Physiological Disturbances Associated With Neonatal Intraventricular Hemorrhage
NCT00665769 TERMINATED NA
Magnesium Sulfate to Prevent Brain Injury in Premature Infants
NCT00065949 UNKNOWN PHASE3
Antenatal and Intrapartum Risk Factors Associated With Neonatal Hypoxic Ischemic Encephalopathy
NCT04364932 UNKNOWN
Neonatal Brain Oxygenation Study
NCT04439968 ACTIVE_NOT_RECRUITING NA
Near-infrared Spectroscopy (NIRS) Neurodevelopmental Outcomes
NCT00464100 COMPLETED
Neurophysiologic Maturation Index for Late Preterm Infants
NCT02156817 COMPLETED
The Role of Cerebral NIRS in Preventing Brain Injury of Very Low Birth Weight Preterm Infants
NCT06729398 COMPLETED NA
Long Term Prognostic of Neonatal Hypoxic Ischemic Encephalopathy With Hypothermia Treatment
NCT02676063 UNKNOWN
Common Neonatal Procedures Could Affect the aEEG in <30 Weeks of Gestational Age Preterms
NCT00722033 UNKNOWN PHASE2
Preterm Neonates Brain Ultrasound With CEUS and Elastography
NCT05694611 WITHDRAWN PHASE3
Cerebral Blood Flow Parameters and Neurobehavioral Development in Infants at Term Age
NCT00676247 COMPLETED
Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis
NCT06434207 RECRUITING
Permissive Hypercapnia and Brain Development in Premature Infants
NCT01361360 COMPLETED
Effects of Delayed Cord Clamp and/or Indomethacin on Preterm Infant Brain Injury
NCT02221219 COMPLETED PHASE1/PHASE2
Prediction of Adverse Outcome Using Fetal MRI in Pregnancies at Risk of Preterm Birth
NCT05164432 RECRUITING NA
Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4
NCT06797219 RECRUITING NA
Follow-up Visit of High Risk Infants
NCT00009633 RECRUITING
Developmental Outcomes
NCT02264808 COMPLETED
Motor Development of Children That Have Surgery as Newborns for Complex Congenital Heart Disease
NCT02781545 COMPLETED
Role of Cord Blood Cytokines and Perinatal Factors in Prediction of Retinopathy of Prematurity
NCT04769661 UNKNOWN